Back
Fennec Pharmaceuticals, Inc. 10K Form
Sell
30
FENC
Fennec Pharmaceuticals, Inc.
Last Price:
$7.45
Seasonality Move:
21.55%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive FENC News And Ratings
See the #1 stock for the next 7 days that we like better than FENC
FENC Financial Statistics
Sales & Book Value
| Annual Sales: | $47.5M |
|---|---|
| Cash Flow: | $1.5M |
| Price / Cash Flow: | 7.15 |
| Annual Sales: | $-0.16 |
| Price / Book: | 82.39 |
Profitability
| EPS (TTM): | -0.23800 |
|---|---|
| Net Income (TTM): | $-6.6M |
| Gross Margin: | $44.4M |
| Return on Equity: | 0% |
| Return on Assets: | -13.45% |
Fennec Pharmaceuticals, Inc. Earnings Forecast
Key Fennec Pharmaceuticals, Inc. Financial Ratios
-
The Gross Profit Margin over the past 25 years for FENC is 93.30%.
-
The Selling, General & Administrative Expenses for FENC have been equal to 87.25% of Gross Profit Margin.
-
The Research & Development expenses have been 0.65% of Revenue.
-
The Net Earning history of FENC is -0.92% of Total Revenues.
-
Per Share Earnings over the last 25 years have been positive in 12 years.
Fennec Pharmaceuticals, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | FENC |
| CUSIP: | 31447P |
| Website: | fennecpharma.com |
Debt
| Debt-to-Equity Ratio: | -4.03 |
|---|---|
| Current Ratio: | 4.69 |
| Quick Ratio: | 4.6 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 9.79 |
FENC Technical Analysis vs Fundamental Analysis
Sell
30
Fennec Pharmaceuticals, Inc. (FENC)
is a Sell
Is Fennec Pharmaceuticals, Inc. a Buy or a Sell?
-
Fennec Pharmaceuticals, Inc. stock is rated a SellThe current Fennec Pharmaceuticals, Inc. [FENC] share price is $7.69. The Score for FENC is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.